SCHEMBL3834036

SCHEMBL3834036

CC(C)(C#N)C(=O)CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5739299 0.83 CES1 (0.39)
SCHEMBL11663108 0.76
SCHEMBL3645353 0.75
SCHEMBL22234947 0.73
SCHEMBL4085921 0.73 LDHA (0.38)
SCHEMBL16823418 0.73
SCHEMBL1013617 0.73 MCL1 (0.41)
SCHEMBL13680145 0.71 MGAM (0.33)
SCHEMBL903352 0.71
SCHEMBL13680122 0.69 GAA (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1412323-B1 PROTECTED 3,5-DIHYDROXY-2,2-DIMETHYL-VALERONITRILES FOR THE SYNTHESIS OF EPOTHILONES AND DERIVATIVES AND METHOD FOR THE PRODUCTION AND USE THEREOF BAYER SCHERING PHARMA AG (DE) 2009-09-30 EP disclosed
EP-1412323-B1 PROTECTED 3,5-DIHYDROXY-2,2-DIMETHYL-VALERONITRILES FOR THE SYNTHESIS OF EPOTHILONES AND DERIVATIVES AND METHOD FOR THE PRODUCTION AND USE THEREOF BAYER SCHERING PHARMA AG (DE) 2009-09-30 EP disclosed
US-7358382-B2 Protected 3,5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and epothilone derivatives and process for the production BAYER SCHERING PHARMA AG (DE) 2008-04-15 US disclosed
US-7358382-B2 Protected 3,5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and epothilone derivatives and process for the production BAYER SCHERING PHARMA AG (DE) 2008-04-15 US disclosed
US-7358382-B2 Protected 3,5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and epothilone derivatives and process for the production BAYER SCHERING PHARMA AG (DE) 2008-04-15 US disclosed
US-7034165-B2 Protected 3,-5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and epothilone derivatives and process for the production SCHERING AG (DE) 2006-04-25 US disclosed
US-20050267306-A1 Protected 3,5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and epothilone derivatives and process for the production BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2005-12-01 US disclosed
EP-1412323-A1 PROTECTED 3,5-DIHYDROXY-2,2-DIMETHYL-VALERONITRILES FOR THE SYNTHESIS OF EPOTHILONES AND DERIVATIVES AND METHOD FOR THE PRODUCTION AND USE THEREOF Schering Aktiengesellschaft (DE) 2004-04-28 EP disclosed
US-20030149281-A1 Protected 3,-5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and epothilone derivatives and process for the production SCHERING AG (DE) 2003-08-07 US disclosed
WO-2003014068-A1 PROTECTED 3.5-DIHYDROXY-2.2-DIMETHYL-VALERONITRILES FOR THE SYNTHESIS OF EPOTHILONES AND DERIVATIVES AND METHOD FOR THE PRODUCTION AND USE THEREOF SCHERING AKTIENGESELLSCHAFT (DE) 2003-02-20 WO disclosed